Jacob M. Chacko
2018
In 2018, Jacob M. Chacko earned a total compensation of $1.6M as President and Chief Executive Officer at Oric Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $92,800 |
|---|---|
| Option Awards | $1,194,442 |
| Salary | $290,000 |
| Other | $57,897 |
| Total | $1,635,139 |
Chacko received $1.2M in option awards, accounting for 73% of the total pay in 2018.
Chacko also received $92.8K in non-equity incentive plan, $290K in salary and $57.9K in other compensation.
Rankings
In 2018, Jacob M. Chacko's compensation ranked 6,738th out of 14,244 executives tracked by ExecPay. In other words, Chacko earned more than 52.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,738 out of 14,244 | 53rd |
Division Manufacturing | 2,572 out of 5,759 | 55th |
Major group Chemicals And Allied Products | 963 out of 2,122 | 55th |
Industry group Drugs | 808 out of 1,811 | 55th |
Industry Pharmaceutical Preparations | 629 out of 1,385 | 55th |
Source: SEC filing on April 26, 2021.
Chacko's colleagues
We found one more compensation record of an executive who worked with Jacob M. Chacko at Oric Pharmaceuticals in 2018.
2018
Pratik Multani
Oric Pharmaceuticals
Chief Medical Officer
News
Oric Pharmaceuticals CEO Jacob Chacko's 2023 pay falls 28% to $3.2M
April 24, 2024
Oric Pharmaceuticals CEO Jacob Chacko's 2022 pay falls 37% to $4.4M
April 26, 2023
Oric Pharmaceuticals CEO Jacob Chacko's 2021 pay rises 19% to $7M
April 27, 2022
Oric Pharmaceuticals CEO Jacob Chacko's 2020 pay jumps 774% to $5.9M
April 26, 2021